ArticleExperimental and therapeutic medicine2025
[Retracted] Interleukin-22 modulates cisplatin sensitivity of osteosarcoma cells by regulating the STAT3 signaling pathway.
Zhiqiang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.